Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sathornsumetee

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Brain Research|September 15, 2000
Assessment of hindlimb gait as a powerful indicator of axonal loss in a murine model of progressive CNS demyelinationD B McGavern, L Zoecklein, S Sathornsumetee, et al.
Brain : a Journal of Neurology|June 16, 2001
Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosisP D Murray, D B McGavern, S Sathornsumetee, et al.
The American Journal of Pathology|October 6, 2000
Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosisS Sathornsumetee, D B McGavern, D R Ure, et al.
Neurology|March 29, 2007
Neurofibromatosis type 2S Sathornsumetee, A DesJardins, D A Reardon, et al.
Colloids and Surfaces. B, Biointerfaces|November 13, 2017
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphomaS Saesoo, S Sathornsumetee, P Anekwiang, et al.
British Journal of Cancer|November 19, 2009
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyD A Reardon, A Desjardins, J J Vredenburgh, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Brain Research|September 15, 2000
Assessment of hindlimb gait as a powerful indicator of axonal loss in a murine model of progressive CNS demyelinationD B McGavern, L Zoecklein, S Sathornsumetee, et al.
Brain : a Journal of Neurology|June 16, 2001
Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosisP D Murray, D B McGavern, S Sathornsumetee, et al.
The American Journal of Pathology|October 6, 2000
Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosisS Sathornsumetee, D B McGavern, D R Ure, et al.
Neurology|March 29, 2007
Neurofibromatosis type 2S Sathornsumetee, A DesJardins, D A Reardon, et al.
Colloids and Surfaces. B, Biointerfaces|November 13, 2017
Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphomaS Saesoo, S Sathornsumetee, P Anekwiang, et al.
British Journal of Cancer|November 19, 2009
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II studyD A Reardon, A Desjardins, J J Vredenburgh, et al.
British Journal of Cancer|October 6, 2012
Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patientsD A Reardon, J E Herndon, K B Peters, et al.
Pageof 1